Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone propionate/salmeterol versus fluticasone propionate in persistent asthma in subjects of African descent
2015-004864-12Phase 4
- Sponsor
- GSK
- Start
- Aug 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of salmeterol + fluticasone and fluticasone propionate in persistent asthma (2 arms), sponsored by GSK. Primary endpoint: Asthma exacerbation rate per patient per year.
02
Drugs
salmeterol + fluticasonefluticasone propionate
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2015-004864-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004864-12.